SCHEMBL6125337

SCHEMBL6125337

Cc1ccc(S(=O)(=O)Oc2cc(S(=O)(=O)O)cc3c(S(=O)(=O)O)c(N=Nc4cc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(O)c5c4N)ccc23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 4/20 0.46
▸ ALDH1A1 P00352 3/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ ENPP2 Q13822 2/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ ESR1 P03372 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ ESR2 Q92731 1/20 0.38
▸ HSD17B10 Q99714 3/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ TP53 P04637 2/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ THRB P10828 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ ALOX15 P16050 2/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ BRCA1 P38398 2/20 0.37
▸ RECQL P46063 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10074812 1.00 CYP1A2 (0.46) CYP1A2ALDH1A1HIF1AENPP2MEN1
SCHEMBL6123859 0.90 CYP1A2 (0.39) CYP1A2ALDH1A1HIF1AENPP2MEN1
SCHEMBL14400964 0.90 CYP1A2 (0.43) CYP1A2ALDH1A1HIF1AENPP2MEN1
SCHEMBL13997571 0.87 CYP1A2 (0.49) CYP1A2ALDH1A1HIF1AENPP2MEN1
SCHEMBL14400951 0.85 CYP1A2 (0.52) CYP1A2ALDH1A1HIF1AENPP2MEN1
SCHEMBL14400843 0.85 CYP1A2 (0.44) CYP1A2ALDH1A1HIF1AENPP2MEN1
SCHEMBL10074811 0.83 ENPP2 (0.38) CYP1A2ALDH1A1HIF1AENPP2MEN1
SCHEMBL6126040 0.83 ENPP2 (0.38) CYP1A2ALDH1A1HIF1AENPP2MEN1
SCHEMBL6123738 0.83 CYP1A2 (0.40) CYP1A2ALDH1A1HIF1AENPP2MEN1
SCHEMBL10284773 0.82 PHLPP2 (0.38) CYP1A2ALDH1A1HIF1AENPP2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140299020-A1 WATER-BASED BLACK INK COMPOSITION, INKJET RECORDING METHOD USING SAME, AND COLORED BODY NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2014-10-09 — — US disclosed
US-8167991-B2 Trisazo compound, ink composition, recording method, and colored article NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2012-05-01 — — US disclosed
EP-1734081-B1 AZO COMPOUND, INK COMPOSITION, AND COLORED OBJECT NIPPON KAYAKU KK (JP) 2011-06-15 — — EP disclosed
US-20090118479-A1 Azo compound, ink composition, recording method and colored article NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-05-07 — — US disclosed
US-7503967-B2 Azo compound, ink composition and colored article NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-03-17 — — US disclosed
US-7503965-B2 Azo compound, ink composition, and colored object NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-03-17 — — US disclosed
US-20090062545-A1 Trisazo Compound, Ink Composition, Recording Method, and Colored Article NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-03-05 — — US disclosed
US-20080292792-A1 Azo Compound, Ink Composition, and Colored Object NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2008-11-27 — — US disclosed
US-20080193660-A1 Azo Compound, Ink Composition and Colored Article NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2008-08-14 — — US disclosed
US-7326288-B2 Trisazo compound, ink composition, and colored object NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2008-02-05 — — US disclosed
US-20070227388-A1 Tetrakisazo Compound, Coloring Matter for Recording, Ink Composition and Colored Article NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2007-10-04 — — US disclosed
US-20070107628-A1 Trisazo compound, ink composition, and colored object NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2007-05-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070107628-A1 Trisazo compound, ink composition, and colored object UFL1, TMT1A, JAK1 CYP1A2 1545/4885ALDH1A1 1635/4885HIF1A 2403/4885
US-20090062545-A1 Trisazo Compound, Ink Composition, Recording Method, and Colored Article JAK1, TMT1A, CDK1 CYP1A2 1285/4885ALDH1A1 2569/4885HIF1A 1639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback